<DOC>
	<DOCNO>NCT01533623</DOCNO>
	<brief_summary>The investigator perform 1-year clinical trial measure objective compliance mandibular advancement device ( MAD ) treatment . The investigator enroll 50 patient receive treatment titratable , duobloc MAD ( RespiDent Butterfly® , RespiDent , Nijlen , Belgium ) participate original study `` Objective versus subjective compliance oral appliance therapy obstructive sleep apnea hypopnea syndrome '' , register Clinical Trials.gov ( NCT01284881 ) . Active microsensors ( TheraMon® , Handelsagentur Gschladt , Hargelsberg , Austria ) provide Handelsagentur Gschladt without cost . The sample interval record do rate 1 measurement per 15 minute ( every 900 second ) . Using sample interval , capacity active microsensor allow data acquisition 100 day period . A follow-up appointment schedule +/- 265 day start original study . A second follow-up visit schedule 1 year start original study . The objective measurement MAD wear time ( total hour wear time mean hour wear per night respective period ) base assumption MAD wear chip record temperature intraorally .</brief_summary>
	<brief_title>The 1 Year Follow-up Objective Oral Appliance Compliance</brief_title>
	<detailed_description>This clinical trial extension trial 10/48/340 , register Clinical Trials.gov ( NCT01284881 ) .</detailed_description>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<criteria>clinical diagnosis sleepdisordered breathing start treatment titratable , duobloc mandibular advancement device participate original study 10/48/340 ( 3 month followup compliance treatment mandibular advancement device ) dental exclusion criterion mandibular advancement device medical contraindication mandibular advancement device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>